RPG Life Sciences Share Price

NSE: RPGLIFE
|
Pharmaceuticals

₹ 2,785.00

-₹33.40 (-1.19%)
1D
Last updated 15 Oct, 2026, 15:29 IST

RPG Life Sciences Share Price Today

As of 15 Oct 2026, RPG Life Sciences share price is ₹2,785.00. The stock opened at ₹2,790.00, compared to its previous close of ₹2,818.40. During today's trading session, RPG Life Sciences share price moved in the range of ₹2,764.10 to ₹2,900.00, with an average price of ₹2,832.05 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,733.00 and a high of ₹3,127.80. On the performance front, RPG Life Sciences share price has increased by 44.78% over the last six months and is up 21.28% on a year-on-year basis.

₹2,764.10
1.19% down today
₹2,900.00
1D LOW
1D HIGH

RPG Life Sciences Returns Calculator

Volume
4,755
Average traded price
₹2,809.86
Last traded time
03:29:47 15 Oct
Last traded quantity
32
Circuit
L
H
₹2,254.80
₹3,382.00
52-week
L
H
₹1,733.00
₹3,127.80
Mkt Cap Cr
4,648.21
P/E
38.85
P/B
7.68
ROA
15.08%
ROE
19.03%
ROCE
24.66%
Quick Ratio
2.71
EV/EBITDA
24.31
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
RPG LifeScience. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
RPG LifeScience. appears overvalued compared to its peers
Step 4 of 5
Earnings
Good
RPG LifeScience. revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,19,619.6934.635.0211.19%13.74%17.33%2.3121.56
Divis Laboratories2,39,714.1581.9614.314.6%15.32%19.56%3.555.94
Torrent Pharmaceuticals1,74,740.9981.0520.784.87%25.49%13.85%0.7538.0
Zydus Lifesciences1,12,817.6824.414.148.57%18.59%17.35%0.9115.05
Laurus Labs1,10,823.44100.8920.7610.38%16.77%16.14%0.6854.45
Cipla1,07,446.7931.63.087.92%11.27%14.95%2.518.23
Dr. Reddy's Laboratories1,03,471.1431.832.665.48%11.07%12.54%1.3516.4
Mankind Pharma96,243.6446.555.97.36%11.74%13.13%0.7425.74
Aurobindo Pharma96,836.1025.762.526.34%9.25%11.76%1.1512.41
Lupin89,391.0416.13.9814.47%23.76%24.88%1.429.55

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

About RPG Life Sciences

ISIN
INE105J01010
Sector Market Cap
₹ 4,648.21 Cr

RPG Life Sciences Limited is an India-based research-based pharmaceutical company. The Company operates in the domestic and international markets in the formulations, generics, and synthetic active pharmaceutical ingredients (APIs) space. Its business portfolio includes domestic formulations, international formulations, and APIs. Its domestic formulation business manufactures and markets branded finished dosage formulations in India. The domestic formulations business has a presence in nephrology, oncology, rheumatology, cardiology, respiratory, pain management, vitamins & minerals, gastroenterology, and gynecology & pediatrics. The International Formulations business operates in the generics and branded generics space across Canada, Europe, Australia, New Zealand, and South America. Its products include Azoran, Mofetyl, Arpimune ME, Azathioprine, Quinfamide, Nicorandil, Haloperidol, Risperidone, Tolvaptan, Spironolactone, Sertraline, Naprosyn, Teristrong, and others.

RPG Life Sciences Financial Highlights

  • Revenue: RPG Life Sciences reported revenue of ₹733.10 crore in FY26 vs ₹666.11 crore in FY25. It showed an increase of 10.06% on a yearly basis.
  • Operating Profit: RPG Life Sciences reported an operating profit of ₹154.20 crore in FY26 vs ₹232.88 crore in FY25. It showed a decrease of 33.79% on a year-on-year basis.
  • Net Profit: RPG Life Sciences reported a net profit of ₹115.17 crore in FY26 vs ₹183.24 crore in FY25. It showed a decrease of 37.15% on a yearly basis.

RPG Life Sciences Quarterly Result Highlights

  • RPG Life Sciences reported revenue of ₹200.39 crore in Jun 2026, compared with ₹189.29 crore in Mar 2026, representing an increase of 5.86% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported an operating profit of ₹41.46 crore in Jun 2026, compared with ₹40.20 crore in Mar 2026, representing an increase of 3.13% on a quarter-on-quarter (QoQ) basis.
  • RPG Life Sciences reported a profit of ₹30.76 crore in Jun 2026, compared with ₹29.90 crore in Mar 2026, reflecting an increase of 2.88% on a QoQ basis.
  • The earnings per share (EPS) of RPG Life Sciences stood at ₹69.64 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
72.95%
FII
0.87%
Other DII
9.89%
Retail and other
16.25%
Mutual funds
0.04%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 20251.00%
Mar 20260.87%
Jun 20260.95%
Sep 20260.87%
1 day
-1.42%
1 week
-1.18%
1 month
+2.20%
1 year
+21.28%
3 years
+113.94%
5 years
+314.95%
Day
Open / Close
Change %
14 Oct 26
₹2,814.80 / ₹2,818.40
+0.42%
13 Oct 26
₹2,848.00 / ₹2,806.60
-1.99%
12 Oct 26
₹2,705.10 / ₹2,863.50
+5.31%
09 Oct 26
₹2,811.70 / ₹2,719.20
-3.29%
Show more

RPG Life Sciences Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Revenue₹707.52₹653.43
Other Income₹25.58₹12.68
Total Revenue₹733.10₹666.11
Total Expenses₹582.80₹515.83
Profit Before Tax₹154.20₹232.88
Tax₹39.03₹49.64
Profit After Tax₹115.17₹183.24
EPS - Basic₹69.64₹110.80
EPS - Diluted₹69.64₹110.80

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Profit before tax₹154.20₹232.88
Income before WC changes₹136.89₹156.66
Change in Assets-₹76.45-₹24.20
Change in Liabilities₹33.28-₹1.85
Change in WC-₹43.17-₹26.05
Cash flow from Operations₹56.50₹77.86
Cash flow from Investing₹85.84-₹41.80
Cash flow from Financing-₹20.58-₹27.08
Total Cash Flow₹121.76₹8.98
Cash (Start of the year)₹28.70₹19.72
Cash (End of the year)₹150.46₹28.70

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025
Non-Current Assets₹233.68₹192.56
Current Assets₹559.48₹465.25
Total Assets₹793.16₹657.81
Current Liabilities₹160.57₹119.83
Net Current Asset₹398.91₹345.42
Non-Current Liabilities₹27.24₹7.45
Equity Capital₹605.35₹530.53
Total Equity & Liabilities₹793.16₹657.81

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹707.52₹653.43₹582.05₹512.81
Other Income₹25.54₹12.68₹7.21₹4.80
Total Revenue₹733.06₹666.11₹589.26₹517.61
Total Expenses₹582.76₹515.83₹471.42₹425.93
Profit Before Tax₹154.20₹232.88₹117.84₹91.68
Tax₹39.03₹49.64₹30.18₹24.04
Profit After Tax₹115.17₹183.24₹87.66₹67.64
EPS - Basic₹69.64₹110.80₹53.01₹40.90
EPS - Diluted₹69.64₹110.80₹53.01₹40.90

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹154.20₹232.88₹117.84₹91.68
Income before WC changes₹136.89₹156.66₹130.76₹104.99
Change in Assets-₹76.44-₹24.20-₹25.44-₹12.96
Change in Liabilities₹33.26-₹1.85₹18.35₹24.02
Change in WC-₹43.18-₹26.05-₹7.09₹11.06
Cash flow from Operations₹56.50₹77.86₹94.36₹90.82
Cash flow from Investing₹51.06-₹41.80-₹79.15-₹105.81
Cash flow from Financing-₹20.58-₹27.08-₹20.31-₹17.12
Total Cash Flow₹86.98₹8.98-₹5.10-₹32.11
Cash (Start of the year)₹28.70₹19.72₹24.82₹56.94
Cash (End of the year)₹115.68₹28.70₹19.72₹24.83

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹268.45₹192.56₹214.78₹155.30
Current Assets₹524.69₹465.25₹298.09₹264.05
Total Assets₹793.14₹657.81₹512.87₹419.35
Current Liabilities₹160.53₹119.83₹130.96₹102.78
Net Current Asset₹364.16₹345.42₹167.13₹161.27
Non-Current Liabilities₹27.24₹7.45₹7.06₹8.97
Equity Capital₹605.37₹530.53₹374.85₹307.60
Total Equity & Liabilities₹793.14₹657.81₹512.87₹419.35
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
49.23
Neutral
ATR (14)
146.95
Neutral
STOCH(9,6)
40.25
Neutral
STOCH RSI (14)
25.15
Neutral
ADX(9)
29.29
Bearish
UO(9)
45.53
Neutral
ROC(12)
-7.61
Bearish
WillR(14)
-67.75
Neutral
Period
Simple value
Exponential vaue
5D
2803.88
2826.66
10D
2870.96
2850.16
20D
2880.14
2847.33
50D
2757.18
2773.74
100D
2620.51
2631.79
Volume trend — traded volume by day
15 Oct0L
14 Oct0L
13 Oct0L
12 Oct0L
9 Oct0L
8 Oct0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
RPG Life Sciences
Pharmaceuticals
Add Stock
Add Another

RPG Life Sciences Share Price FAQs

Disclaimer: The information on this page, including prices, charts, financials, ratios, and other data, is provided for informational and educational purposes only. It is not investment advice, a research report, or a recommendation or solicitation to buy, sell, or hold any security. Data is sourced from third parties and exchanges, may be delayed, and is not guaranteed to be accurate, complete, or timely. Upstox is not liable for any loss arising from its use.